Dror Ortho-Design (DROR) EBITDA Margin (2020 - 2021)
Dror Ortho-Design's (DROR) quarterly EBITDA Margin came in at 2974.92% in Q3 2021, up 63.32% quarter-over-quarter from 8110.0% in Q2 2021.
Powered by 
Analysis
Dror Ortho-Design (DROR) EBITDA Margin (2020 - 2021) Analysis & Trends
Dror Ortho-Design has disclosed EBITDA Margin across 2 years of filings, most recently posting 2974.92% for Q3 2021.
- In Q3 2021, EBITDA Margin changed N/A year-over-year to 2974.92%; the TTM figure through Dec 2021 stood at 6631.7% (up 1013900.0% YoY), while the FY2021 annual figure was 6631.7%, up 1013900.0% from the prior year.
- EBITDA Margin came in at 2974.92% for Q3 2021 at Dror Ortho-Design, up from 8110.0% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 2974.92% in Q3 2021 to a low of 8110.0% in Q2 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Align Technology | 10.73 Bn | 9.63 Bn | 757.43 Mn | 14.58% |
| 2 | Envista Holdings | 4.22 Bn | 3.10 Bn | 407.00 Mn | 10.99% |
| 3 | Dentsply Sirona | 2.12 Bn | 1.88 Bn | 493.00 Mn | 9.13% |
| 4 | Milestone Scientific | 34.86 Mn | 32.25 Mn | 1.56 Mn | -38.30% |
| 5 | Dror Ortho-Design | 9.77 Mn | 9.68 Mn | - | - |
| 6 | Vivos Therapeutics | 3.20 Mn | 1.40 Mn | 2.95 Mn | -87.81% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2021 | -2,974.92% |
| Jun 30, 2021 | -8,110.00% |
| Mar 31, 2021 | -3,970.79% |
| Mar 31, 2020 | -5,028.80% |